← Alle mensen

TH

Te-Chun Hsia

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Tepotinib plus gefitinib versus chemotherapie bij EGFR-gemuteerd NSCLC met MET-resistentie: INSIGHT 2

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 mei 2023

Pembrolizumab plus ipilimumab of placebo bij PD-L1≥50% NSCLC: KEYNOTE-598 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juli 2021

Emibetuzumab plus erlotinib versus erlotinib bij gevorderd NSCLC: fase II

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2020-01